AZD5156 / AstraZeneca 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD5156 / AstraZeneca
SUPERNOVA, NCT05648110 / 2022-002378-95: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies () Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies () Sub-study

Active, not recruiting
2/3
3882
Europe, Canada, US, RoW
AZD5156 (Parent study Sentinel Safety Cohort), Placebo (Parent study Sentinel Safety Cohort), EVUSHELD™ (Parent study Main Cohort), EVUSHELD™, AZD3152 (Parent study Main Cohort), Placebo (Parent study Main Cohort), AZD3152 (Sub-study), AZD7442 - EVUSHELD™ (Sub-study), AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152
AstraZeneca, AstraZeneca AB
COVID-19, SARS-CoV-2
03/24
02/25

Download Options